Systemic Heparin Use in Upper Extremity Arteriovenous Access Maintenance for Dialysis: A Meta-Analysis of Randomized...

Area of Science:

• Vascular Surgery
• Nephrology
• Evidence-Based Medicine

Background:

• Arteriovenous fistulas and grafts for hemodialysis frequently fail early due to thrombosis.
• Systemic heparinization's effect on perioperative patency is not well-established.

Purpose of the Study:

• To evaluate the efficacy and safety of perioperative systemic heparin in maintaining upper-limb vascular access patency.
• To assess the impact of heparin on early thrombosis and bleeding complications.

Main Methods:

• A meta-analysis of randomized controlled trials sourced from PubMed, Embase, and Cochrane databases.
• Included adults undergoing arteriovenous fistula or graft placement for hemodialysis.
• Pooled data using a random-effects model to determine odds ratios for patency and bleeding.

Main Results:

• Six studies with 1,265 patients were analyzed; 731 received heparin.
• Systemic heparinization significantly reduced early patency loss (OR 0.58, 95% CI 0.37-0.92).
• Heparin use was linked to a higher risk of bleeding complications (OR 4.24, 95% CI 1.13-15.9).

Conclusions:

• Perioperative systemic heparinization enhances early patency rates for hemodialysis vascular access.
• Increased bleeding risk is associated with heparin use.
• Heparin is a potential strategy against early thrombosis but requires balancing against bleeding risks.